Genetic Epidemiology of Adult Onset Glioma

This study has been completed.
Sponsor:
Collaborator:
DR. Kathleen Egan
Information provided by:
Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier:
NCT00283569
First received: January 26, 2006
Last updated: January 18, 2010
Last verified: January 2010
  Purpose

To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.


Condition Intervention
Adult-Onset Glioma
Other: Mouth Swab, Toe Nail Clippings, Questionnaires

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genetic Epidemiology of Adult-Onset Glioma

Resource links provided by NLM:


Further study details as provided by Kentuckiana Cancer Institute:

Biospecimen Retention:   Samples With DNA

Saliva, Toe Nail Clippings


Estimated Enrollment: 100
Study Start Date: May 2004
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Mouth Swab, Toe Nail Clippings, Questionnaires
    The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Detailed Description:

Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with Glioma and a Control

Criteria

Inclusion Criteria:

  • primary glioma of any stage
  • diagnosed within 4 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00283569

Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
DR. Kathleen Egan
Investigators
Principal Investigator: Renato V. LaRocca, MD Director
  More Information

No publications provided

Responsible Party: Renato V. LaRocca, MD, Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier: NCT00283569     History of Changes
Other Study ID Numbers: mrbt1-03-132, MRBTC2003-01
Study First Received: January 26, 2006
Last Updated: January 18, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Kentuckiana Cancer Institute:
Glioma

Additional relevant MeSH terms:
Glioma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors

ClinicalTrials.gov processed this record on October 23, 2014